Register a trial

The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT04761354




Registration number
NCT04761354
Ethics application status
Date submitted
10/02/2021
Date registered
18/02/2021

Titles & IDs
Public title
Predicting Reduction of Hypertension After Adrenalectomy for Primary Aldosteronism: a Multicenter Analysis
Scientific title
Characteristics Predicting Clinically Relevant Reduction of Hypertension Following Adrenalectomy for Primary Aldosteronism: a Multicenter Analysis
Secondary ID [1] 0 0
16-196/C
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Primary Aldosteronism Due to Aldosterone Producing Adenoma 0 0
Primary Aldosteronism 0 0
Primary Aldosteronism Due to Conn Adenoma 0 0
Condition category
Condition code
Cancer 0 0 0 0
Bowel - Back passage (rectum) or large bowel (colon)
Metabolic and Endocrine 0 0 0 0
Other endocrine disorders
Cardiovascular 0 0 0 0
Hypertension

Intervention/exposure
Study type
Observational
Patient registry
Target follow-up duration
Target follow-up type
Description of intervention(s) / exposure
University Medical Center Utrecht - Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma

University Medical Center Groningen - Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma

Vu University Medical Center Amsterdam - Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma

University Medical Center Maastricht - Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma

Academic Medical Center Amsterdam - Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma

Istituto di Semeiotica Chirurgica Roma - Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma

University of California San Francisco - Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma

Northwestern Memorial Hospital - Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma

Weill Cornell Medical Center - Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma

Columbia University Medical Center - Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma

University of Chicago Medical Center - Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma

M.D. Anderson Cancer Center - Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma

Boston Medical Center - Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma

University Health Network Toronto - Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma

Montreal General Hospital - McGill University - Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma

University of Sydney - Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Postoperative blood pressure measurement
Timepoint [1] 0 0
6 months postoperative
Primary outcome [2] 0 0
antihypertensive medication use
Timepoint [2] 0 0
6 months postoperative (corresponding to the entered postoperative blood pressure)
Primary outcome [3] 0 0
resolution of hypertension
Timepoint [3] 0 0
6 months postoperative
Secondary outcome [1] 0 0
Postoperative serum potassium level
Timepoint [1] 0 0
6 months postoperative
Secondary outcome [2] 0 0
Postoperative plasma aldosterone level in lying and standing position
Timepoint [2] 0 0
6 months postoperative
Secondary outcome [3] 0 0
Postoperative plasma renin activity in lying and standing position
Timepoint [3] 0 0
6 months postoperative
Secondary outcome [4] 0 0
Postoperative aldosterone to renin ratio
Timepoint [4] 0 0
6 months postoperative
Secondary outcome [5] 0 0
Postoperative plasma creatinine level
Timepoint [5] 0 0
6 months postoperative
Secondary outcome [6] 0 0
Pathology
Timepoint [6] 0 0
6 months postoperative

Eligibility
Key inclusion criteria
* All patients who underwent unilateral adrenalectomy between 2010 and 2016 for APA.
* Patients with biochemical evidence of primary aldosteronism who underwent adrenalectomy on account of an aldosterone-producing adenoma(APA), proven by Computerized Tomography(CT) or Magnetic Resonance Imaging(MRI) or Adrenal Venous Sampling(AVS).
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
* Age <18 years.
* Missing or incomplete data about preoperative blood pressure and number of antihypertensive drugs.
* Missing or incomplete follow-up data about postoperative blood pressure and number of antihypertensive drugs. We aim enter the blood pressure and number of antihypertensive drugs closest to 6 months after adrenalectomy.

Study design
Purpose
Duration
Selection
Timing
Retrospective
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
26/03/2016
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
26/03/2017
Sample size
Target
Accrual to date
Final
514
Recruitment in Australia
Recruitment state(s)
NSW
Recruitment hospital [1] 0 0
University of Sydney - Sydney
Recruitment postcode(s) [1] 0 0
- Sydney
Recruitment outside Australia
Country [1] 0 0
United States of America
State/province [1] 0 0
California
Country [2] 0 0
United States of America
State/province [2] 0 0
Illinois
Country [3] 0 0
United States of America
State/province [3] 0 0
Massachusetts
Country [4] 0 0
United States of America
State/province [4] 0 0
New York
Country [5] 0 0
United States of America
State/province [5] 0 0
Texas
Country [6] 0 0
Canada
State/province [6] 0 0
Ontario
Country [7] 0 0
Canada
State/province [7] 0 0
Quebec
Country [8] 0 0
Italy
State/province [8] 0 0
Lazio
Country [9] 0 0
Netherlands
State/province [9] 0 0
Limburg
Country [10] 0 0
Netherlands
State/province [10] 0 0
Noord-Holland
Country [11] 0 0
Netherlands
State/province [11] 0 0
Groningen

Funding & Sponsors
Primary sponsor type
Other
Name
UMC Utrecht
Address
Country
Other collaborator category [1] 0 0
Other
Name [1] 0 0
University of California, San Francisco
Address [1] 0 0
Country [1] 0 0
Other collaborator category [2] 0 0
Other
Name [2] 0 0
Northwestern Memorial Hospital
Address [2] 0 0
Country [2] 0 0
Other collaborator category [3] 0 0
Other
Name [3] 0 0
Weill Medical College of Cornell University
Address [3] 0 0
Country [3] 0 0
Other collaborator category [4] 0 0
Other
Name [4] 0 0
Columbia University
Address [4] 0 0
Country [4] 0 0
Other collaborator category [5] 0 0
Other
Name [5] 0 0
University of Chicago
Address [5] 0 0
Country [5] 0 0
Other collaborator category [6] 0 0
Other
Name [6] 0 0
M.D. Anderson Cancer Center
Address [6] 0 0
Country [6] 0 0
Other collaborator category [7] 0 0
Other
Name [7] 0 0
Boston Medical Center
Address [7] 0 0
Country [7] 0 0
Other collaborator category [8] 0 0
Other
Name [8] 0 0
University Health Network, Toronto
Address [8] 0 0
Country [8] 0 0
Other collaborator category [9] 0 0
Other
Name [9] 0 0
Montreal General Hospital
Address [9] 0 0
Country [9] 0 0
Other collaborator category [10] 0 0
Other
Name [10] 0 0
University of Sydney
Address [10] 0 0
Country [10] 0 0
Other collaborator category [11] 0 0
Other
Name [11] 0 0
University Medical Center Groningen
Address [11] 0 0
Country [11] 0 0
Other collaborator category [12] 0 0
Other
Name [12] 0 0
Maastricht University Medical Center
Address [12] 0 0
Country [12] 0 0
Other collaborator category [13] 0 0
Other
Name [13] 0 0
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Address [13] 0 0
Country [13] 0 0
Other collaborator category [14] 0 0
Other
Name [14] 0 0
Catholic University of the Sacred Heart
Address [14] 0 0
Country [14] 0 0
Other collaborator category [15] 0 0
Other
Name [15] 0 0
Amsterdam UMC, location VUmc
Address [15] 0 0
Country [15] 0 0

Ethics approval
Ethics application status

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Menno R Vriens, MD
Address 0 0
UMC Utrecht
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
No/undecided IPD sharing reason/comment


What supporting documents are/will be available?




Results publications and other study-related documents



Results not provided in https://clinicaltrials.gov/study/NCT04761354